Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

5.5K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
5.5K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.1K
Inflammation01:38

Inflammation

54.6K
Overview
54.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone marrow edema in osteoarthritis and bone trauma. Diagnose and treatment.

La Clinica terapeutica·2025
Same author

Physiopathology and pharmacological protection of periprosthetic bone.

La Clinica terapeutica·2025
Same author

The choice of surgical aortic valve replacement type and mid-term outcomes in 50 to 65-year-olds: results of the AUTHEARTVISIT study.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2025
Same author

Cervical myelopathy as an atypical presentation of antineutrophil cytoplasmic antibody-associated vasculitis in a patient affected by silicosis: a case report and literature overview.

Reumatismo·2024
Same author

Expert opinion on the management of patients with osteoporosis with anabolic drugs in Italy.

Reumatismo·2024
Same author

Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS).

Journal of endocrinological investigation·2024
Same journal

Effectiveness of Focal Muscle Vibration in Post-Anterior Cruciate Ligament Reconstruction Rehabilitation: A Case Report.

La Clinica terapeutica·2026
Same journal

Violence Against Women as a Public-Health Exposure: Biological Embedding, Medico-Legal Caution and Precision Prevention in the EpiWe Framework.

La Clinica terapeutica·2026
Same journal

Suicide of the Work-Disabled Individual Affected by Neoplasia with Unfavorable Prognosis: Evidence-Based Legal Medicine in Reconstructing the Causal Link.

La Clinica terapeutica·2026
Same journal

The therapeutic potential of N-acetylcysteine across multiple organ systems: a narrative review.

La Clinica terapeutica·2026
Same journal

Mesotherapy in Pain Management in Primary Care: A Narrative Review and Practice-Oriented Appraisal.

La Clinica terapeutica·2026
Same journal

Bone Marrow Edema in Rheumatic Diseases: Incidence, Diagnosis, and Therapeutic Implications. A Narrative Review.

La Clinica terapeutica·2026
See all related articles

Related Experiment Video

Updated: Aug 27, 2025

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
09:04

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging

Published on: June 8, 2017

6.6K

Bone Marrow Edema: pathogenetic features.

L Molfetta1, A Florian1, G Saviola2

  • 1University of Genoa, School of Medical and Pharmacological Sciences, DISC Department, Research Center of Osteoporosis and Osteoarticular Pathologies, Genoa, Italy.

La Clinica Terapeutica
|September 26, 2022
PubMed
Summary
This summary is machine-generated.

Bone marrow edema (BME), first described in 1988, appears as a high MRI signal in subchondral bone. Understanding BME's diverse causes, from osteoarthritis to inflammatory diseases, guides effective treatment strategies.

Keywords:
Bone marrow edemabisphosphonatesimaginginflammation

More Related Videos

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K
Tracking Mouse Bone Marrow Monocytes In Vivo
12:08

Tracking Mouse Bone Marrow Monocytes In Vivo

Published on: February 27, 2015

9.6K

Related Experiment Videos

Last Updated: Aug 27, 2025

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
09:04

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging

Published on: June 8, 2017

6.6K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K
Tracking Mouse Bone Marrow Monocytes In Vivo
12:08

Tracking Mouse Bone Marrow Monocytes In Vivo

Published on: February 27, 2015

9.6K

Area of Science:

  • Musculoskeletal Radiology
  • Pathophysiology
  • Medical Imaging

Background:

  • Bone marrow edema (BME) is characterized by high signal intensity on fluid-sensitive MRI sequences within the subchondral bone.
  • First described in 1988, BME is observed across various musculoskeletal conditions, including osteoarthritis, inflammatory and rheumatic diseases, and bone marrow edema syndromes.
  • Despite similar imaging findings, these conditions exhibit distinct pathophysiological, histological, and clinical characteristics.

Purpose of the Study:

  • To systematically review and describe the pathogenetic features of bone marrow edema.
  • To highlight the diagnostic and therapeutic implications of differentiating various causes of BME.
  • To provide a comprehensive overview of BME as a significant imaging finding in musculoskeletal diseases.

Main Methods:

  • Systematic review of relevant scientific literature.
  • Selection of key contributions to elucidate pathogenetic mechanisms.
  • Analysis of pathophysiological, histological, and clinical differences among BME causes.

Main Results:

  • Bone marrow edema is a common imaging finding in diverse musculoskeletal pathologies.
  • Distinguishing between different etiologies of BME is crucial for appropriate therapeutic management.
  • Therapeutic approaches vary, with bisphosphonates, NSAIDs, and corticosteroids used for general BME, while TNF-α inhibitors target inflammatory origins.

Conclusions:

  • Bone marrow edema is a critical diagnostic consideration in musculoskeletal imaging.
  • Understanding the specific etiology of BME is essential for tailoring patient treatment.
  • Further research into the pathogenetic features of BME will refine diagnostic and therapeutic strategies.